Streetbeat News

Analyst Ratings

PPBI

Piper Sandler analyst Matthew Clark maintains an Overweight rating on Pacific Premier Bancorp (NASDAQ:PPBI) and raises the price target from $28 to $29.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:42 pm

PDS

Piper Sandler analyst Luke Lemoine maintains an Overweight rating on Precision Drilling (NYSE:PDS) and raises the price target from $90 to $107.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:41 pm

ORRF

Piper Sandler analyst Casey Orr Whitman maintains a Neutral rating on Orrstown Finl Servs (NASDAQ:ORRF) and raises the price target from $20 to $25.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:41 pm

NOV

Piper Sandler analyst Luke Lemoine has maintained a Neutral rating on NOV (NYSE:NOV) and lowered the price target from $21 to $20.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:40 pm

APLS

Needham analyst Joseph Stringer has maintained a 'Buy' rating on Apellis Pharmaceuticals (NASDAQ:APLS) but lowered the price target from $110 to $60.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:40 pm

MBIN

Piper Sandler analyst Nathan Rice maintains an Overweight rating on Merchants Bancorp (NASDAQ:MBIN) and raises the price target from $31 to $38.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:38 pm

INBK

Piper Sandler analyst Nathan Race maintains a Neutral rating on First Internet (NASDAQ:INBK) and raises the price target from $17 to $25.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:37 pm

TROW

UBS analyst Brennan Hawken maintains a 'Sell' rating on T. Rowe Price Gr (NASDAQ:TROW) and raises the price target from $83 to $90.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 4:37 pm

HP

Piper Sandler analyst Luke Lemoine maintains an Overweight rating on Helmerich & Payne (NYSE:HP) and raises the price target from $45 to $51.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:37 pm

HOMB

Piper Sandler analyst Stephen Scouten maintains an Overweight rating on Home BancShares (NYSE:HOMB) and raises the price target from $25 to $27.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 4:36 pm